ROSWELL PARK CANCER INSTITUTE
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $6.2M
- Transactions
- 136
- Companies
- 29
- Average per transaction
- $45,440
Who reported the payments
| Merck | $2,175,632 |
| AbbVie | $1,405,265 |
| Pfizer | $1,250,463 |
| Amgen | $415,048 |
| AstraZeneca | $288,963 |
| Jazz Pharmaceuticals Inc. | $230,035 |
| Intuitive Surgical | $155,297 |
| Apellis Pharmaceuticals, Inc. | $77,600 |
| Beckman Coulter, Inc. | $51,578 |
| Stemline Therapeutics Inc. | $32,066 |
| Roche Diagnostics Corporation | $23,333 |
| Tersera Therapeutics LLC | $14,299 |
| Bristol Myers Squibb | $13,671 |
| Life Technologies Corporation | $11,974 |
| Kyowa Kirin Co., Ltd | $10,000 |
| Stryker | $6,629 |
| EMD Millipore Corporation | $5,551 |
| Pinnacle Biologics, Inc | $4,000 |
| Advanced Accelerator Applications | $2,500 |
| Olympus America Inc. | $2,209 |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,000 |
| Angiodynamics, Inc. | $950 |
| Bio-rad Laboratories, Inc. | $432 |
| Linvatec Corporation | $99 |
| Medivators Inc. | $66 |
| Qiagen, LLC | $50 |
| Johnson & Johnson | $39 |
| Oxford GENE Technology Inc | $30 |
| Luminex Corporation | $19 |